BRIEF published on 12/09/2025 at 18:35, 4 months 4 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 4 months 4 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
BRIEF published on 12/09/2025 at 18:35, 4 months 4 days ago Theraclion soumet Sonovein à la FDA après d'importants progrès FDA Theraclion SONOVEIN Varices HIFU
BRIEF published on 12/09/2025 at 18:35, 4 months 4 days ago Theraclion soumet le Sonovein à la FDA après une année de succès clés Soumission À La FDA SONOVEIN Réalisations Réglementaires Traitement Des Varices Preuves Cliniques
PRESS RELEASE published on 12/09/2025 at 18:30, 4 months 4 days ago Informations privilégiées / Autres communiqués Theraclion annonce la soumission de Sonovein à la FDA après une année de progrès réglementaires et cliniques, avec des résultats encourageants et des avancées significatives en Europe et en Chine FDA Theraclion SONOVEIN Varices HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 4 months 4 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 5 months 15 days ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
BRIEF published on 10/29/2025 at 18:35, 5 months 15 days ago Theraclion annonce ses résultats financiers et ses progrès stratégiques pour le premier semestre 2025. Résultats Financiers Croissance Des Revenus Expansion Du Marché Étude Américaine Progression De La Certification
PRESS RELEASE published on 10/29/2025 at 18:30, 5 months 15 days ago Inside Information / News release on accounts, results Theraclion reports successful pivotal study, CE certification, GB 9706.1-2020 certification; 89% revenue increase and 23% operating loss reduction in 2025 half-year results Revenue Increase Operating Loss Reduction CE Certification Pivotal Study Theraclion
PRESS RELEASE published on 10/29/2025 at 18:30, 5 months 15 days ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce ses récentes avancées majeures et ses résultats financiers du premier semestre 2025, confirmant une forte efficacité de sa plateforme robotique HIFU pour le traitement des varices Résultats Financiers Theraclion Varices Avancées Majeures HIFU
Published on 04/14/2026 at 14:00, 11 minutes ago GameSquare Expands Share Repurchase Authorization to $15 Million
Published on 04/14/2026 at 14:00, 11 minutes ago Revolve Announces Change to Board of Directors and Provides Corporate Update
Published on 04/14/2026 at 13:30, 41 minutes ago Nextech3D.ai Achieves Cash Flow Positive Operations After AI‑Enabled Optimization; Blockchain Ticketing With Fiat Checkout Ready
Published on 04/14/2026 at 13:15, 56 minutes ago Bayhorse Silver Announces Brokered LIFE Offering for Gross Proceeds of up to C$4.0 Million
Published on 04/14/2026 at 13:05, 1 hour 6 minutes ago Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Published on 04/14/2026 at 14:00, 11 minutes ago Mutares has sold all subsidiaries of inTime Group to Tawin Holdings Group
Published on 04/14/2026 at 13:20, 50 minutes ago Annual Shareholder Meeting of Comet Holding AG approves all agenda items
Published on 04/14/2026 at 13:19, 51 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG initiates a cash capital increase while preserving subscription rights with an issue volume of up to approximately EUR 10.3 million.
Published on 04/14/2026 at 13:04, 1 hour 6 minutes ago Aroundtown announces successful result of the voluntary Exchange Offer for GCP shares, increasing its holding in GCP to 81.5%
Published on 04/14/2026 at 08:30, 5 hours 41 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 18 hours 56 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 19 hours 56 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 19 hours 56 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 20 hours 2 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
